Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1994 May 28;308(6941):1381–1382. doi: 10.1136/bmj.308.6941.1381

Somatostatin in gastroenterology.

A Shulkes, J S Wilson
PMCID: PMC2540337  PMID: 7912595

Full text

PDF
1381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassi C., Falconi M., Lombardi D., Briani G., Vesentini S., Camboni M. G., Pederzoli P. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group. Digestion. 1994;55 (Suppl 1):41–47. doi: 10.1159/000201188. [DOI] [PubMed] [Google Scholar]
  2. Bell G. I., Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci. 1993 Jan;16(1):34–38. doi: 10.1016/0166-2236(93)90050-v. [DOI] [PubMed] [Google Scholar]
  3. Binmoeller K. F., Harris A. G., Dumas R., Grimaldi C., Delmont J. P. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut. 1992 Aug;33(8):1129–1133. doi: 10.1136/gut.33.8.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burroughs A. K., McCormick P. A., Hughes M. D., Sprengers D., D'Heygere F., McIntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990 Nov;99(5):1388–1395. doi: 10.1016/0016-5085(90)91166-4. [DOI] [PubMed] [Google Scholar]
  5. Büchler M., Friess H., Klempa I., Hermanek P., Sulkowski U., Becker H., Schafmayer A., Baca I., Lorenz D., Meister R. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg. 1992 Jan;163(1):125–131. doi: 10.1016/0002-9610(92)90264-r. [DOI] [PubMed] [Google Scholar]
  6. Cello J. P., Grendell J. H., Basuk P., Simon D., Weiss L., Wittner M., Rood R. P., Wilcox C. M., Forsmark C. E., Read A. E. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial. Ann Intern Med. 1991 Nov 1;115(9):705–710. doi: 10.7326/0003-4819-115-9-705. [DOI] [PubMed] [Google Scholar]
  7. Christiansen J., Ottenjann R., Von Arx F. Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding. Gastroenterology. 1989 Sep;97(3):568–574. doi: 10.1016/0016-5085(89)90626-4. [DOI] [PubMed] [Google Scholar]
  8. Gorden P., Comi R. J., Maton P. N., Go V. L. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med. 1989 Jan 1;110(1):35–50. doi: 10.7326/0003-4819-110-1-35. [DOI] [PubMed] [Google Scholar]
  9. Gray J. L., Debas H. T., Mulvihill S. J. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Arch Surg. 1991 Oct;126(10):1231–1236. doi: 10.1001/archsurg.1991.01410340073010. [DOI] [PubMed] [Google Scholar]
  10. Jaramillo J. L., de la Mata M., Miño G., Costán G., Gómez-Camacho F. Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices. A randomized pilot study. J Hepatol. 1991 Jan;12(1):100–105. doi: 10.1016/0168-8278(91)90917-z. [DOI] [PubMed] [Google Scholar]
  11. Lamberts S. W., Chayvialle J. A., Krenning E. P. The visualization of gastroenteropancreatic endocrine tumors. Digestion. 1993;54 (Suppl 1):92–97. doi: 10.1159/000201085. [DOI] [PubMed] [Google Scholar]
  12. Layer P., vd Ohe M., Müller M. K., Beglinger C. Effects of somatostatin on the exocrine pancreas. Scand J Gastroenterol. 1991 Feb;26(2):129–136. doi: 10.3109/00365529109025022. [DOI] [PubMed] [Google Scholar]
  13. McKay C. J., Imrie C. W., Baxter J. N. Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis? Gut. 1993 Nov;34(11):1622–1626. doi: 10.1136/gut.34.11.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nelson-Piercy C., Hammond P. J., Gwilliam M. E., Khandan-Nia N., Myers M. J., Ghatei M. A., Bloom S. R. Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J Clin Endocrinol Metab. 1994 Feb;78(2):329–336. doi: 10.1210/jcem.78.2.7906279. [DOI] [PubMed] [Google Scholar]
  15. Nightingale J. M., Lennard-Jones J. E., Walker E. R., Farthing M. J. Jejunal efflux in short bowel syndrome. Lancet. 1990 Sep 29;336(8718):765–768. doi: 10.1016/0140-6736(90)93238-k. [DOI] [PubMed] [Google Scholar]
  16. Shulkes A. Somatostatin: physiology and clinical applications. Baillieres Clin Endocrinol Metab. 1994 Jan;8(1):215–236. doi: 10.1016/s0950-351x(05)80232-0. [DOI] [PubMed] [Google Scholar]
  17. Sung J. J., Chung S. C., Lai C. W., Chan F. K., Leung J. W., Yung M. Y., Kassianides C., Li A. K. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet. 1993 Sep 11;342(8872):637–641. doi: 10.1016/0140-6736(93)91758-e. [DOI] [PubMed] [Google Scholar]
  18. Torres A. J., Landa J. I., Moreno-Azcoita M., Argüello J. M., Silecchia G., Castro J., Hernandez-Merlo F., Jover J. M., Moreno-Gonzales E., Balibrea J. L. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg. 1992 Jan;127(1):97–100. doi: 10.1001/archsurg.1992.01420010115018. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES